Beacon Capital Management LLC (Tennessee)’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-334
Closed -$3.38K – 1103
2023
Q4
$3.38K Hold
334
– – ﹤0.01% 715
2023
Q3
$4.17K Hold
334
– – ﹤0.01% 731
2023
Q2
$4.17K Hold
334
– – ﹤0.01% 731
2023
Q1
$3.9K Buy
+334
New +$4.26K ﹤0.01% 678

Other funds holding HCAT

Beacon Capital Management LLC (Tennessee)'s HCAT Position: Q1 2024 in Review

Beacon Capital Management LLC (Tennessee) sold out of Health Catalyst (HCAT) in Q1 2024, closing a stake of 334 shares — an estimated $3.38K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in HCAT in Q1 2023 and held it in 4 quarters. The position peaked at $4.17K in Q3 2023. 174 funds tracked by Wall St. Rank hold HCAT as of Q1 2024.

  • Beacon Capital Management LLC (Tennessee) reported no remaining Health Catalyst position as of Q1 2024 after selling out during the quarter.
  • Beacon Capital Management LLC (Tennessee) sold 334 Health Catalyst shares in Q1 2024, an estimated $3.38K.
  • Beacon Capital Management LLC (Tennessee) first reported a position in Health Catalyst in Q1 2023 and held it in 4 quarters.
  • Beacon Capital Management LLC (Tennessee)'s Health Catalyst position peaked at $4.17K in Q3 2023.
  • 174 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2024.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q1 2024, filed 16 May 2024.